Abstract
Green tea (Camellia sinensis) has shown to exert cardioprotective benefits in observational studies. The objective of this clinical trial was to assess the effects of green tea on features of metabolic syndrome and inflammation in obese subjects.
| Original language | English |
|---|---|
| Pages (from-to) | 206-13 |
| Number of pages | 8 |
| Journal | Nutrition (Burbank, Los Angeles County, Calif.) |
| Volume | 27 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2011 |
Bibliographical note
Copyright © 2011 Elsevier Inc. All rights reserved.UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adult
- Antioxidants
- Biological Markers
- C-Reactive Protein
- Camellia sinensis
- Cardiovascular Diseases
- Catechin
- Female
- Humans
- Inflammation
- Intercellular Adhesion Molecule-1
- Interleukin-1beta
- Interleukin-6
- Male
- Metabolic Syndrome X
- Middle Aged
- Obesity
- Phytotherapy
- Plant Extracts
- Single-Blind Method
- Tea
- Vascular Cell Adhesion Molecule-1
Fingerprint
Dive into the research topics of 'Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver